Bryan Dransart

Bryan Dransart serves as the Sr. Director of Global Business Development for Chromatography at Repligen Corporation since May 2025, bringing extensive expertise from prior roles in leading pharmaceutical companies. At BioMarin Pharmaceutical Inc., from August 2023 to May 2025, Bryan held the positions of Sr. Principal Engineer/Director of Global Process Services, where responsibilities included leading a global technology transfer initiative, and Director of CMC Leadership, overseeing cross-functional CMC development for gene therapy projects. Prior to that, Bryan was with Allogene Therapeutics, leading drug product process development for CAR-T therapies. Bryan's experience also includes leadership roles at Sutro Biopharma, Gilead Sciences, and Amgen, focusing on process development and characterization across various biotechnology platforms. Bryan earned a BS in Chemical Engineering/Bioengineering from UCLA.